Clinical Trials in Phillip, Australian Capital Territory

A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis

NCT ID: NCT06921759

This clinical trial is looking at a new treatment called lebrikizumab for adults and teenagers who have moderate-to-severe atopic hand and foot dermatitis, a condition that causes itchy and painful...

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT ID: NCT05889182

This clinical trial is studying a medication called upadacitinib to see how effective and safe it is for treating moderate to severe hidradenitis suppurativa (HS) in adults and adolescents who have...

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06468228

This clinical trial is studying a new drug called lutikizumab to see how well it works and how safe it is for treating moderate to severe hidradenitis suppurativa (HS), a painful skin condition tha...

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

NCT ID: NCT05618028

This clinical trial is investigating the safety and effectiveness of a new oral medication called ABBV-525 for adults with certain types of B-cell cancers, such as diffuse large B-cell lymphoma and...

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06799000

This clinical trial is investigating a new treatment called remibrutinib for adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes lumps and sores. The ...

Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis

NCT ID: NCT04991116

This clinical trial is looking at the long-term safety and effectiveness of a medication called Tildrakizumab for people with Psoriatic Arthritis, a condition that causes joint pain and skin proble...

Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies

NCT ID: NCT04170283

A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis

NCT ID: NCT06380907

This clinical trial is studying a new treatment called ZL-1102, which is a topical gel designed for adults with chronic plaque psoriasis, a common skin condition that causes red, scaly patches. The...